The Effects of Tourniquet Use in Total Knee Arthroplasty

NCT ID: NCT02429713

Last Updated: 2015-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tourniquets are still widely used in total knee arthroplasty, but are associated with several adverse effects. Most of previous studies did not randomize the participants so the baseline difference of the patients might have influenced the outcome. Therefore, investigators conducted a randomized controlled trial, in which all the patients received staged bilateral TKA with two different durations of tourniquet use. Investigators aimed to quantify the effect of tourniquet use on reducing blood loss and to evaluate the impact of tourniquet use on functional and clinical outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fifty participants who underwent staged bilateral TKA were recruited in this study. On one side, the tourniquet was inflated immediately before incision and deflated after the hardening of the cement. On the other side the tourniquet was inflated immediately before cement application and deflated after its hardening. Blood loss, operating time, transfusion rate, postoperative pain, limb swelling, deep vein thrombosis (DVT) incidence and clinical outcomes were monitored for comparison.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Short-duration tourniquet group

The tourniquet was inflated immediately before cement application and deflated after its hardening

Group Type EXPERIMENTAL

Short-duration tourniquet

Intervention Type PROCEDURE

Short-duration tourniquet group:inflate the tourniquet immediately before cement application and deflated after its hardening

Long-duration tourniquet group

The tourniquet was inflated immediately before incision and deflated after the hardening of the cement

Group Type ACTIVE_COMPARATOR

Long-duration tourniquet

Intervention Type PROCEDURE

Long-duration tourniquet group: inflate the tourniquet immediately before incision and deflated after the hardening of the cement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short-duration tourniquet

Short-duration tourniquet group:inflate the tourniquet immediately before cement application and deflated after its hardening

Intervention Type PROCEDURE

Long-duration tourniquet

Long-duration tourniquet group: inflate the tourniquet immediately before incision and deflated after the hardening of the cement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged 50 years or over
* classified as American Society of Anesthesiologists ASA 1-2.

Exclusion Criteria

* coagulopathy,
* uncontrolled hypertension,
* peripheral vascular disease and
* patients with BMI≥35
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wang Kai

resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jianhao Lin, M.D.

Role: STUDY_DIRECTOR

Peking University People's Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY. Tourniquet use in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2011 Jul;19(7):1121-30. doi: 10.1007/s00167-010-1342-7. Epub 2010 Dec 15.

Reference Type BACKGROUND
PMID: 21161177 (View on PubMed)

Hernandez AJ, Almeida AM, Favaro E, Sguizzato GT. The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty. Clinics (Sao Paulo). 2012 Sep;67(9):1053-7. doi: 10.6061/clinics/2012(09)12.

Reference Type BACKGROUND
PMID: 23018303 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PekingUPH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Tourniquet on UKA
NCT02465684 UNKNOWN NA